
DepYmed
NY-based DepYmed Inc. develops novel therapeutics for cancer and rare diseases, focusing on PTP1B inhibitors and copper chelators.
- 11
- Private company
- Farmingdale, NY, USUnited States
DepYmed Inc. is a New York-based therapeutic development company focused on creating novel treatments for cancer and rare diseases. The company specializes in developing potent inhibitors of the enzyme PTP1B for HER2-positive breast cancer and Rett Syndrome. Additionally, DepYmed has a portfolio of small molecules with copper-chelating properties, targeting diseases like Wilson Disease.
DepYmed has made significant strides in the field of therapeutic development, particularly with its innovative PTP1B inhibitors and copper chelators. These advancements have the potential to address unmet medical needs in both oncology and rare disease treatment, positioning DepYmed as a key player in the biotech industry.
Similar Companies
Thyritope Biosciences

Syndevrx
syndevrx.com

Delpor
delpor.com

PeptiMed
peptimed.com

Promontory Therapeutics
promontorytx.com

Innox
innoxpharma.com

PTC Therapeutics
ptcbio.com

Remedy Plan
remedyplan.com

JDP Therapeutics

Biotheryx
biotheryx.com

NovelMed Therapeutics
novelmed.com

Pharmatrophix
pharmatrophix.com

D&D Pharmatech

OrphoMed
orphomed.com

Therapyx
therapyxinc.com

Differentiated Therapeutics
dxtherapeutics.com
On Demand Therapeutics

Aztherapies

DemeRx
demerx.com

Resolvyx Pharmaceuticals
Quick Facts
Who are DepYmed's competitors?
Companies similar to DepYmed include Thyritope Biosciences, Syndevrx, Delpor and PeptiMed.
When was DepYmed founded?
DepYmed was founded in 2014.
Where is DepYmed's headquarters located?
DepYmed's headquarters is located in Farmingdale, NY, US.
When was DepYmed's last funding round?
DepYmed's most recent funding round was for $8.3M (USD) in April 2021.
How much disclosed funding has DepYmed raised?
As of Apr 13, 2021, DepYmed has disclosed funding of $10.4M (USD). Undisclosed round amounts are excluded.
How many employees does DepYmed have?
DepYmed has 11 employees as of Feb 5, 2024.
Classification
- Ownership
- Technology
- Geographic Exposure
- Customer
- Main Product
- Tags
- NAICS
- 540000Professional, Scientific, and Technical Services
- 541714Research and Development in Biotechnology (except Nanobiotechnology)
- 541000Professional, Scientific, and Technical Services
- 541700Scientific Research and Development Services
- 541710Research and Development in the Physical, Engineering, and Life Sciences
- SIC
- 8700Engineering, Accounting, Research, Management, And Related Services
- 8730Research, Development, And Testing Services
- 8731Commercial Physical and Biological Research
- Industry
- —Biotechnology Companies
- —Health Care Companies
- —Medical Organizations
- —Pharmaceutical Companies
Show 13 more industry codes
- NAICS
- 320000Manufacturing
- 325400Pharmaceutical and Medicine Manufacturing
- 620000Health Care and Social Assistance
- 325000Chemical Manufacturing
- 623000Nursing and Residential Care Facilities
- 325410Pharmaceutical and Medicine Manufacturing
- 325412Pharmaceutical Preparation Manufacturing
- SIC
- 2800Chemicals And Allied Products
- 8000Health Services
- 2830Drugs
- 8040Offices And Clinics Of Other Health Practitioners
- 2834Pharmaceutical Preparations
- 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified